Andrew J. Schwab's Net Worth
$2.49 Billion
Who is Andrew J. Schwab?
Andrew J. Schwab has an estimated net worth of $2.49 Billion. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Skye Bioscience, Inc., CinCor Pharma, Inc., Flexion Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS, INC., 5:01 Acquisition Corp., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., and EPIRUS Biopharmaceuticals, Inc..
SEC CIK
Andrew J. Schwab's CIK is 0001598549
Past Insider Trading and Trends
2019 was Andrew J. Schwab's most active year for acquiring shares with 28 total transactions. Andrew J. Schwab's most active month to acquire stocks was the month of January. 2022 was Andrew J. Schwab's most active year for disposing of shares, totalling 56 transactions. Andrew J. Schwab's most active month to dispose stocks was the month of October. 2022 saw Andrew J. Schwab paying a total of $25,520,000.00 for 4,937,646 shares, this is the most they've acquired in one year. In 2019 Andrew J. Schwab cashed out on 13,292,745 shares for a total of $54,804,484.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.57% | -250.00K |
$22.20 | -$5,550,000.00 | 2.36M |
Jun 21
| |||
Form 4
| -5.60% | -154.84K |
$24.25 | -$3,754,954.14 | 2.61M |
Mar 18
| |||
Form 4
| -14.35% | -464.83K |
—
|
—
| 2.77M |
Feb 20
| |||
Form 4
| -7.49% | -262.15K |
$21.88 | -$5,734,596.87 | 3.24M |
Jan 22
| |||
Form 4
| +103.40% | 3.5M |
$17.00 | $1,955,000.00 | 6.88M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $13.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.09% | 4.08M |
$20.00 |
—
| 7.99M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $43.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -23.10% | -800.00K |
$13.66 | -$10,928,000.00 | 2.66M |
Nov 11
| |||
Form 4
| +103.84% | 3.15M |
$10.00 | $7,500,000.00 | 6.18M |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rallybio Corp (RLYB) Snapshot price: $1.6679
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.03% | -100.00K |
$8.20 | -$820,000.00 | 2.38M |
Mar 7
| |||
Form 4
| -3.87% | -150.00K |
$12.50 | -$1,875,000.00 | 3.73M |
Jun 3
| |||
Form 4
| -2.51% | -100.00K |
$13.00 | -$1,300,000.00 | 3.88M |
May 23
| |||
Form 4
| -5.01% | -210.00K |
$13.05 | -$2,740,500.00 | 3.98M |
Feb 8
| |||
Form 4
| +77.83% | 615.38K |
$13.00 | $7,999,992.00 | 1.41M |
Aug 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARVINAS, INC. (ARVN) Snapshot price: $47.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.61% | -312.36K |
—
|
—
| 3.3M |
Sep 16
| |||
Form 4
| -9.61% | -810.00K |
$21.89 | -$17,714,700.00 | 7.62M |
Jun 27 - Jun 28
| |||
Form 4
| -4.11% | -190.00K |
$19.65 | -$3,733,500.00 | 4.44M |
Jun 7
| |||
Form 4
| -7.24% | -361.13K |
$14.16 | -$5,112,683.82 | 4.63M |
Mar 28
| |||
Form 4
|
∞
| 4.99M |
—
|
—
| 4.99M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |